OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma
Summary: Lung adenocarcinoma (LUAD) is one of the leading causes of cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) plays an important role in malignant tumor progression. Recently, accumulating evidence has shown that autophagy is involved in the regulation of EMT-induced mi...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-02-01
|
| Series: | iScience |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224000944 |
| _version_ | 1827373982609833984 |
|---|---|
| author | Yali Wang Lin Shi Yuchao He Wenchen Gong Yanyan Cui Ran Zuo Yu Wang Yi Luo Liwei Chen Zhiyong Liu Peng Chen Hua Guo |
| author_facet | Yali Wang Lin Shi Yuchao He Wenchen Gong Yanyan Cui Ran Zuo Yu Wang Yi Luo Liwei Chen Zhiyong Liu Peng Chen Hua Guo |
| author_sort | Yali Wang |
| collection | DOAJ |
| description | Summary: Lung adenocarcinoma (LUAD) is one of the leading causes of cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) plays an important role in malignant tumor progression. Recently, accumulating evidence has shown that autophagy is involved in the regulation of EMT-induced migration. Therefore, the exploration of targets to inhibit EMT by targeting autophagy is important. In this study, we found that OVO-like zinc finger 2 (OVOL2) may be a key target for regulating autophagy-induced EMT. Firstly, we found that OVOL2 expression was dramatically downregulated in LUAD. Low expression of OVOL2 is an indicator of poor prognosis in LUAD. In vitro experiments have shown that downregulation of OVOL2 expression induces EMT, thereby promoting malignant biological behavior, such as proliferation, migration, and invasion of LUAD cells. Interestingly, autophagy is a key step in regulating OVOL2 and inducing EMT. Furthermore, OVOL2 regulates autophagy through the MAPK signaling pathway, ultimately inhibiting the malignant progression of LUAD. |
| first_indexed | 2024-03-08T11:25:51Z |
| format | Article |
| id | doaj.art-7e86a80b9c494654b4fde70f126f2c41 |
| institution | Directory Open Access Journal |
| issn | 2589-0042 |
| language | English |
| last_indexed | 2024-03-08T11:25:51Z |
| publishDate | 2024-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | iScience |
| spelling | doaj.art-7e86a80b9c494654b4fde70f126f2c412024-01-26T05:34:23ZengElsevieriScience2589-00422024-02-01272108873OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinomaYali Wang0Lin Shi1Yuchao He2Wenchen Gong3Yanyan Cui4Ran Zuo5Yu Wang6Yi Luo7Liwei Chen8Zhiyong Liu9Peng Chen10Hua Guo11Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; Department of Thoracic Oncology, Lung Cancer Diagnosis and Treatment Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Department of Oncology, Affiliated Hospital of Chifeng University, Chifeng, Inner Mongolia 024000, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; Department of Thoracic Oncology, Lung Cancer Diagnosis and Treatment Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Department of Oncology, Inner Mongolia Autonomous Region People’s Hospital, Hohhot, Inner Mongolia 010000, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, ChinaNational Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, ChinaDepartment of Oncology, Affiliated Hospital of Chifeng University, Chifeng, Inner Mongolia 024000, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; Department of Thoracic Oncology, Lung Cancer Diagnosis and Treatment Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; Department of Thoracic Oncology, Lung Cancer Diagnosis and Treatment Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, ChinaDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Corresponding authorDepartment of Thoracic Oncology, Lung Cancer Diagnosis and Treatment Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Corresponding authorDepartment of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Corresponding authorSummary: Lung adenocarcinoma (LUAD) is one of the leading causes of cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) plays an important role in malignant tumor progression. Recently, accumulating evidence has shown that autophagy is involved in the regulation of EMT-induced migration. Therefore, the exploration of targets to inhibit EMT by targeting autophagy is important. In this study, we found that OVO-like zinc finger 2 (OVOL2) may be a key target for regulating autophagy-induced EMT. Firstly, we found that OVOL2 expression was dramatically downregulated in LUAD. Low expression of OVOL2 is an indicator of poor prognosis in LUAD. In vitro experiments have shown that downregulation of OVOL2 expression induces EMT, thereby promoting malignant biological behavior, such as proliferation, migration, and invasion of LUAD cells. Interestingly, autophagy is a key step in regulating OVOL2 and inducing EMT. Furthermore, OVOL2 regulates autophagy through the MAPK signaling pathway, ultimately inhibiting the malignant progression of LUAD.http://www.sciencedirect.com/science/article/pii/S2589004224000944PathophysiologyMolecular biologyCancer |
| spellingShingle | Yali Wang Lin Shi Yuchao He Wenchen Gong Yanyan Cui Ran Zuo Yu Wang Yi Luo Liwei Chen Zhiyong Liu Peng Chen Hua Guo OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma iScience Pathophysiology Molecular biology Cancer |
| title | OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma |
| title_full | OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma |
| title_fullStr | OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma |
| title_full_unstemmed | OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma |
| title_short | OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma |
| title_sort | ovol2 induces autophagy mediated epithelial mesenchymal transition by the erk1 2 mapk signaling in lung adenocarcinoma |
| topic | Pathophysiology Molecular biology Cancer |
| url | http://www.sciencedirect.com/science/article/pii/S2589004224000944 |
| work_keys_str_mv | AT yaliwang ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT linshi ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT yuchaohe ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT wenchengong ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT yanyancui ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT ranzuo ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT yuwang ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT yiluo ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT liweichen ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT zhiyongliu ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT pengchen ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma AT huaguo ovol2inducesautophagymediatedepithelialmesenchymaltransitionbytheerk12mapksignalinginlungadenocarcinoma |